PA
Perceptive Advisors Portfolio holdings
AUM
$2.67B
1-Year Return
73.17%
This Quarter Return
+37.7%
1 Year Return
+73.17%
3 Year Return
+837.18%
5 Year Return
+928.4%
10 Year Return
+11,818.46%
AUM
$2.61B
AUM Growth
+$680M
(+35%)
Cap. Flow
+$219M
Cap. Flow
% of AUM
8.37%
Top 10 Holdings %
Top 10 Hldgs %
54.25%
Holding
163
New
39
Increased
29
Reduced
18
Closed
28
Top Buys
| 1 |
Neurocrine Biosciences
NBIX
|
$74.4M |
| 2 |
AVXS
AveXis, Inc. Common Stock
AVXS
|
$38.7M |
| 3 |
XLRN
Acceleron Pharma Inc.
XLRN
|
$33.8M |
| 4 |
Puma Biotechnology
PBYI
|
$22.8M |
| 5 |
CBAY
Cymabay Therapeutics
CBAY
|
$18.9M |
Top Sells
| 1 |
Sarepta Therapeutics
SRPT
|
$36.7M |
| 2 |
RDUS
Radius Health, Inc.
RDUS
|
$29.2M |
| 3 |
Vertex Pharmaceuticals
VRTX
|
$21.1M |
| 4 |
Jazz Pharmaceuticals
JAZZ
|
$13.3M |
| 5 |
SIOX
Sio Gene Therapies Inc. Common Stock
SIOX
|
$13.3M |
Sector Composition
| 1 | Healthcare | 95.78% |
| 2 | Industrials | 0.33% |
| 3 | Consumer Discretionary | 0.07% |
| 4 | Technology | 0.01% |
| 5 | Energy | 0% |
